|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,550.00 ARS | +0.32% |
|
+0.65% | -21.52% |
| Market Cap | 125B 84.03M 73.05M 67.99M 62.43M 118M 8.02B 120M 801M 315M 3.99B 316M 309M 13.39B | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 356B 239M 208M 193M 178M 335M 22.83B 341M 2.28B 895M 11.37B 898M 878M 38.11B | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
| 1 day | +0.32% | ||
| 1 week | +0.65% | ||
| 1 month | -1.27% | ||
| 3 months | -5.20% | ||
| 6 months | -22.11% | ||
| Current year | -21.52% |
| 1 week | 1,520 | 1,595 | |
| 1 month | 1,495 | 1,610 | |
| Current year | 1,420 | 2,130 | |
| 1 year | 945 | 2,300 | |
| 3 years | 480.5 | 2,300 | |
| 5 years | 215 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 29/04/2025 | |
| Corporate Officer/Principal | - | 29/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.32% | +0.65% | +3.68% | +190.26% | 84.03M | ||
| -0.53% | -3.95% | +55.23% | +152.74% | 1,024B | ||
| +0.21% | -2.68% | +55.61% | +53.02% | 618B | ||
| -2.51% | -3.25% | +32.76% | +67.76% | 443B | ||
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | ||
| -0.14% | -0.24% | +34.41% | +39.01% | 297B | ||
| -0.69% | -0.30% | +11.55% | +12.93% | 264B | ||
| -7.37% | -4.40% | -2.54% | -43.87% | 209B | ||
| -0.64% | +2.43% | +30.52% | +64.49% | 208B | ||
| -0.82% | +0.70% | +15.96% | +71.01% | 162B | ||
| Average | -1.21% | -0.95% | +27.47% | +63.80% | 357.38B | |
| Weighted average by Cap. | -0.99% | -1.93% | +39.24% | +72.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 91.79B 61.63M 53.57M 49.86M 45.78M 86.46M 5.88B 87.79M 588M 231M 2.93B 231M 226M 9.82B | 127B 85.08M 73.96M 68.84M 63.2M 119M 8.12B 121M 811M 318M 4.04B 320M 313M 13.56B |
| Net income | 23.85B 16.01M 13.92M 12.95M 11.89M 22.46M 1.53B 22.81M 153M 59.92M 761M 60.12M 58.8M 2.55B | 3.09B 2.07M 1.8M 1.68M 1.54M 2.91M 198M 2.95M 19.77M 7.76M 98.52M 7.79M 7.61M 330M |
| Net Debt | 134B 89.73M 78M 72.6M 66.66M 126M 8.57B 128M 856M 336M 4.26B 337M 330M 14.3B | 231B 155M 135M 126M 115M 218M 14.81B 221M 1.48B 581M 7.37B 583M 570M 24.72B |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | ARS 1,550.00 | +0.32% | 26,344 |
| 30/07/26 | ARS 1,545.00 | +0.32% | 27,313 |
| 29/07/26 | ARS 1,540.00 | -.--% | 31,156 |
| 28/07/26 | ARS 1,540.00 | +0.65% | 400 |
| 27/07/26 | ARS 1,530.00 | -0.65% | 34,559 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions
















